Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

DFNA5 anticorps (N-Term)

DFNA5 Reactivité: Humain WB, IHC (p), FACS Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN5531009
  • Antigène Voir toutes DFNA5 Anticorps
    DFNA5 (Deafness, Autosomal Dominant 5 (DFNA5))
    Épitope
    • 15
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 59-87, N-Term
    Reactivité
    • 30
    • 20
    • 18
    • 2
    • 2
    • 2
    • 1
    Humain
    Hôte
    • 42
    • 3
    Lapin
    Clonalité
    • 44
    • 1
    Polyclonal
    Conjugué
    • 18
    • 4
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp DFNA5 est non-conjugé
    Application
    • 33
    • 18
    • 13
    • 13
    • 11
    • 8
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS)
    Purification
    This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis
    Immunogène
    This DFNA5 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 59-87 amino acids from the N-terminal region of human DFNA5.
    Isotype
    Ig Fraction
    Top Product
    Discover our top product DFNA5 Anticorps primaire
  • Indications d'application
    For WB starting dilution is: 1:1000

    For IHC-P starting dilution is: 1:50~100

    For FACS starting dilution is: 1:10~50
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    2 mg/mL
    Buffer
    Supplied in PBS with 0.09 % (W/V) sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
  • Antigène
    DFNA5 (Deafness, Autosomal Dominant 5 (DFNA5))
    Autre désignation
    DFNA5 (DFNA5 Produits)
    Synonymes
    anticorps Dfna5h, anticorps fk59f08, anticorps zgc:91916, anticorps wu:fc41e05, anticorps wu:fk59f08, anticorps MGC83660, anticorps ICERE-1, anticorps 2310037D07Rik, anticorps 4932441K13Rik, anticorps EG14210, anticorps Fin15, anticorps gasdermin E, anticorps gasdermin Eb, anticorps DFNA5, deafness associated tumor suppressor, anticorps gasdermin E L homeolog, anticorps Gsdme, anticorps gsdmeb, anticorps DFNA5, anticorps gsdme.L, anticorps GSDME
    Sujet
    Hearing impairment is a heterogeneous condition with over 40 loci described. DFNA5 is expressed in fetal cochlea, however, its function is not known.
    Poids moléculaire
    55 kDa
    ID gène
    1687
    UniProt
    O60443
    Pathways
    Sensory Perception of Sound
Vous êtes ici:
Support technique